{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:39:50Z","timestamp":1791329990440,"version":"4.3.1"},"reference-count":33,"publisher":"EDP Sciences","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Sci (Paris)"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1051\/medsci\/20102611943","type":"journal-article","created":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T19:04:33Z","timestamp":1299006273000},"page":"943-949","source":"Crossref","is-referenced-by-count":39,"title":["R\u00e9sistance aux antibiotiques chez<i>Staphylococcus aureus<\/i>"],"prefix":"10.1051","volume":"26","author":[{"given":"Oana","family":"Dumitrescu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Dauwalder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Boisset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-\u00c9lisabeth","family":"Reverdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Tristan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Vandenesch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"250","published-online":{"date-parts":[[2010,11,15]]},"reference":[{"key":"R1","doi-asserted-by":"crossref","unstructured":"Oliveira DC, Tomasz A, Lencastre H. Secrets of success of a human pathogen\u00a0: molecular evolution of pandemic clones of meticillin-resistantStaphylococcus aureus. Lancet Infect Dis2002 ; 2 : 180-9.","DOI":"10.1016\/S1473-3099(02)00227-X"},{"key":"R2","doi-asserted-by":"crossref","unstructured":"Kuroda M, Ohta T, Uchiyama I, et al. Whole genome sequencing of meticillin-resistantStaphylococcus aureus. Lancet2001 ; 357 : 1225-40.","DOI":"10.1016\/S0140-6736(00)04403-2"},{"key":"R3","doi-asserted-by":"crossref","unstructured":"Bukharie HA, Abdelhadi MS, Saeed IA, et al. Emergence of methicillinresistantStaphylococcus aureusas a community pathogen.Diagn Microbiol Infect Dis2001 ; 40 : 1-4.","DOI":"10.1016\/S0732-8893(01)00242-5"},{"key":"R4","doi-asserted-by":"crossref","unstructured":"Ito T, Okuma K, Ma XX, et al. Insights on antibiotic resistance ofStaphylococcus aureusfrom its whole genome : genomic island SCC.Drug Resist Updat2003 ; 6 : 41-52.","DOI":"10.1016\/S1368-7646(03)00003-7"},{"key":"R5","doi-asserted-by":"crossref","unstructured":"Hiramatsu K, Cui L, Kuroda M, et al. The emergence and evolution of methicillin-resistantStaphylococcus aureus.Trends Microbiol2001 ; 9 : 486-93.","DOI":"10.1016\/S0966-842X(01)02175-8"},{"key":"R6","doi-asserted-by":"crossref","unstructured":"Katayama Y, Ito T, Hiramatsu K. A new class of genetic element, staphylococcus cassette chromosome mec, encodes methicillin resistance inStaphylococcus aureus. Antimicrob Agents Chemother2000 ; 44 : 1549-55.","DOI":"10.1128\/AAC.44.6.1549-1555.2000"},{"key":"R7","doi-asserted-by":"crossref","unstructured":"Ito T, Ma XX, Takeuchi F, et al. Novel type V staphylococcal cassette chromosome mec driven by a novel cassette chromosome recombinase, ccrC.Antimicrob Agents Chemother2004\u00a0; 48\u00a0: 2637-51.","DOI":"10.1128\/AAC.48.7.2637-2651.2004"},{"key":"R8","doi-asserted-by":"crossref","unstructured":"Oliveira DC, de Lencastre H. Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistantStaphylococcus aureus. Antimicrob Agents Chemother2002 ; 46 : 2155-61.","DOI":"10.1128\/AAC.46.7.2155-2161.2002"},{"key":"R9","doi-asserted-by":"crossref","unstructured":"International working group on the classification of staphylococcal cassette chromosome elements (IWG-SCC). Classification of staphylococcal cassette chromosome mec (SCCmec) : guidelines for reporting novelSCCmecelements.Antimicrob Agents Chemother2009 ; 53 : 4961-7.","DOI":"10.1128\/AAC.00579-09"},{"key":"R10","doi-asserted-by":"crossref","unstructured":"Zhang K, McClure JA, Elsayed S, et al. Novel staphylococcal cassette chromosome mec type, tentatively designated type VIII, harboring class A mec and type 4 ccr gene complexes in a Canadian epidemic strain of methicillin-resistantStaphylococcus aureus. Antimicrob Agents Chemother2009 ; 53 : 531-40.","DOI":"10.1128\/AAC.01118-08"},{"key":"R11","doi-asserted-by":"crossref","unstructured":"Hiramatsu K, Katayama Y, Yuzawa H, et al. Molecular genetics of methicillin-resistantStaphylococcus aureus. Int J Med Microbiol2002 ; 292 : 67-74.","DOI":"10.1078\/1438-4221-00192"},{"key":"R12","doi-asserted-by":"crossref","unstructured":"Katayama Y, Takeuchi F, Ito T, et al. Identification in methicillin-susceptibleStaphylococcus hominisof an active primordial mobile genetic element for the staphylococcal cassette chromosome mec of methicillin-resistantStaphylococcus aureus. J Bacteriol2003 ; 185 : 2711-22.","DOI":"10.1128\/JB.185.9.2711-2722.2003"},{"key":"R13","doi-asserted-by":"crossref","unstructured":"Tsubakishita S, Kuwahara-Arai K, Baba T, et al. Staphylococcal cassette chromosome mec-like element inMacrococcus caseolyticus. Antimicrob Agents Chemother2010 ; 54 : 1469-75.","DOI":"10.1128\/AAC.00575-09"},{"key":"R14","doi-asserted-by":"crossref","unstructured":"Dufour P, Gillet Y, Bes M, et al. Community-acquired methicillin-resistantStaphylococcus aureusinfections in France\u00a0: emergence of a single clone that produces Panton-Valentine leukocidin.Clin Infect Dis2002 ; 35 : 819-24.","DOI":"10.1086\/342576"},{"key":"R15","doi-asserted-by":"crossref","unstructured":"Woodin AM. Purification of the two components of leucocidin fromStaphylococcus aureus. Biochem J1960 ; 75 : 158-65.","DOI":"10.1042\/bj0750158"},{"key":"R16","doi-asserted-by":"crossref","unstructured":"Konig B, Prevost G, Piemont Y, et al. Effects ofStaphylococcus aureusleukocidins on inflammatory mediator release from human granulocytes.J Infect Dis1995 ; 171 : 607-13.","DOI":"10.1093\/infdis\/171.3.607"},{"key":"R17","doi-asserted-by":"crossref","unstructured":"Gillet Y, Issartel B, Vanhems P, et al. Association betweenStaphylococcus aureusstrains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients.Lancet2002 ; 359 : 753-9.","DOI":"10.1016\/S0140-6736(02)07877-7"},{"key":"R18","doi-asserted-by":"crossref","unstructured":"Vandenesch F, Naimi T, Enright MC, et al. Community-acquired methicillinresistantStaphylococcus aureuscarrying Panton-Valentine leukocidin genes : worldwide emergence.Emerg Infect Dis2003 ; 9 : 978-84.","DOI":"10.3201\/eid0908.030089"},{"key":"R19","doi-asserted-by":"crossref","unstructured":"Dauwalder O, Lina G, Durand G, et al. Epidemiology of invasive methicillinresistantStaphylococcus aureusclones collected in France in 2006 and 2007.J Clin Microbiol2008 ; 46 : 3454-8.","DOI":"10.1128\/JCM.01050-08"},{"key":"R20","doi-asserted-by":"crossref","unstructured":"Durand G, Bes M, Meugnier H, et al. Detection of new methicillin-resistantStaphylococcus aureusclones containing the toxic shock syndrome toxin 1 gene responsible for hospital and community-acquired infections in France.J Clin Microbiol2006 ; 44 : 847-53.","DOI":"10.1128\/JCM.44.3.847-853.2006"},{"key":"R21","doi-asserted-by":"crossref","unstructured":"Hiramatsu K, Aritaka N, Hanaki H, et al. Dissemination in Japanese hospitals of strains ofStaphylococcus aureusheterogeneously resistant to vancomycin.Lancet1997 ; 350 : 1670-3.","DOI":"10.1016\/S0140-6736(97)07324-8"},{"key":"R22","doi-asserted-by":"crossref","unstructured":"Sancak B, Ercis S, Menemenlioglu D, et al. Methicillin-resistantStaphylococcus aureusheterogeneously resistant to vancomycin in a Turkish university hospital.J Antimicrob Chemother2005 ; 56 : 519-23.","DOI":"10.1093\/jac\/dki272"},{"key":"R23","doi-asserted-by":"crossref","unstructured":"Wootton M, Howe RA, Hillman R, et al. A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin inStaphylococcus aureusin a UK hospital.J Antimicrob Chemother2001 ; 47 : 399-403.","DOI":"10.1093\/jac\/47.4.399"},{"key":"R24","doi-asserted-by":"crossref","unstructured":"Cui L, Iwamoto A, Lian JQ, et al. Novel mechanism of antibiotic resistance originating in vancomycin-intermediateStaphylococcus aureus.Antimicrob Agents Chemother2006 ; 50 : 428-38.","DOI":"10.1128\/AAC.50.2.428-438.2006"},{"key":"R25","doi-asserted-by":"crossref","unstructured":"Swenson JM, Anderson KF, Lonsway DR,et al. Accuracy of commercial and reference susceptibility testing methods for detecting vancomycin-intermediateStaphylococcus aureus.J Clin Microbiol2009 ; 47 : 2013-7.","DOI":"10.1128\/JCM.00221-09"},{"key":"R26","doi-asserted-by":"crossref","unstructured":"Steinkraus G, White R, Friedrich L. Vancomycin MIC creep in non-vancomycin-intermediateStaphylococcus aureus(VISA), vancomycin-susceptible clinical methicillin-resistantS. aureus(MRSA) blood isolates from 2001-05.J Antimicrob Chemother2007 ; 60 : 788-94.","DOI":"10.1093\/jac\/dkm258"},{"key":"R27","doi-asserted-by":"crossref","unstructured":"Ho PL, Lo PY, Chow KH,et al. Vancomycin MIC creep in MRSA isolates from 1997 to 2008 in a healthcare region in Hong Kong.J Infect2010 ; 60 : 140-5.","DOI":"10.1016\/j.jinf.2009.11.011"},{"key":"R28","doi-asserted-by":"crossref","unstructured":"Gould IM. Clinical relevance of increasing glycopeptide MICs againstStaphylococcus aureus.Int J Antimicrob Agents2008 ; 31 (suppl 2) : 1-9.","DOI":"10.1016\/S0924-8579(08)70002-5"},{"key":"R29","doi-asserted-by":"crossref","unstructured":"Sakoulas G, Moise-Broder PA, Schentag J,et al. Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistantStaphylococcus aureusbacteremia.J Clin Microbiol2004 ; 42 : 2398-402.","DOI":"10.1128\/JCM.42.6.2398-2402.2004"},{"key":"R30","doi-asserted-by":"crossref","unstructured":"Maclayton DO, Suda KJ, Coval KA,et al. Case-control study of the relationship between MRSA bacteremia with a vancomycin MIC of 2 microg\/mL and risk factors, costs, and outcomes in inpatients undergoing hemodialysis.Clin Ther2006 ; 28 : 1208-16.","DOI":"10.1016\/j.clinthera.2006.08.003"},{"key":"R31","doi-asserted-by":"crossref","unstructured":"Soriano A, Marco F, Martinez JA,et al. Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistantStaphylococcus aureusbacteremia.Clin Infect Dis2008 ; 46 : 193-200.","DOI":"10.1086\/588256"},{"key":"R32","doi-asserted-by":"crossref","unstructured":"Vandenesh F, Lina G, Gillet Yet al. Chronique d\u2019une controverse sur une bact\u00e9rie \u00e9quip\u00e9e pour tuer.Med Sci (Paris)2009 ; 25 : 984-6.","DOI":"10.1051\/medsci\/20092511984"},{"key":"R33","doi-asserted-by":"crossref","unstructured":"Cattoir V, Leclercq R. Les ent\u00e9rocoques r\u00e9sistants aux glycopeptides.Med Sci (Paris)2010 ; 26 : 936-42.","DOI":"10.1051\/medsci\/20102611936"}],"container-title":["m\u00e9decine\/sciences"],"original-title":[],"link":[{"URL":"http:\/\/www.medecinesciences.org\/10.1051\/medsci\/20102611943\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T22:24:01Z","timestamp":1560032641000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.medecinesciences.org\/10.1051\/medsci\/20102611943"}},"subtitle":["Les points-cl\u00e9s en 2010"],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":33,"journal-issue":{"issue":"11"},"alternative-id":["medsci20102611p943"],"URL":"https:\/\/doi.org\/10.1051\/medsci\/20102611943","relation":{},"ISSN":["0767-0974","1958-5381"],"issn-type":[{"value":"0767-0974","type":"print"},{"value":"1958-5381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}